Global Brain Cancer Therapeutics Market Research Report: Forecast (2025-2030)

Market Definition

Brain cancer therapeutics refers to the medical treatment and strategies used to manage and treat brain cancer which involve malignant growth or tumors in the brain. These therapies aim to eliminate the growth of the tumor in the brain.

Market Insights & Analysis: Global Brain Cancer Therapeutics Market (2025-30):

The Global Brain Cancer Therapeutics Market size was valued at around USD 3.3 billion in 2024 and is projected to reach USD 5.1 billion by 2030. Along with this, the market is estimated to grow at a CAGR of around 7.3% during the forecast period, i.e., 2025-30. This market is undergoing significant growth, driven by multiple factors like the robust pipeline of new drugs and therapies undergoing clinical trials and the rising awareness about brain tumor treatments. A strong pipeline of innovative medicines in clinical trial stages indicates how pharmaceutical companies and various research institutions are committed to addressing medical needs. For instance, as per the Ivy Brain Tumor Center in 2024, about 1.4 million individuals worldwide are living with malignant brain tumors, while up to 256,000 new cases may occur in the coming years. Public awareness about brain tumors as life-threatening conditions is playing a vital role in opening up windows of early detection and better treatment outcomes. The increasing awareness of the symptoms of brain tumors allows for early diagnosis, and improved survival chances of patients.

*Boost strategic growth with in-depth market analysis - Get a free sample preview today!

Governments across the globe are also increasing support for brain cancer treatments. The global government's focus on expanding healthcare infrastructure and subsidizing treatment costs is pivotal in driving the brain cancer therapeutics market. For instance, in the United States, Medicare, Medicaid, and the VA ensure proper and accessible treatment and patient services. In 2024 FDA approved a drug by Johns Hopkins discovery for the treatment of brain cancer called IDH Mutant low-grade glioma. Also, funding dedicated to brain cancer research and related awareness efforts reflects the importance of governments’ aim in dealing with this critical health issue. The Bolstering Research and Innovation Now (BRAIN) Act is a vast push for increased funding in research, collaboration, and awareness for brain tumors. The National Cancer Institute and the National Institutes of Health also play a major role in funding and supporting brain cancer research. These organizations dedicate significant funds to developing innovative therapies and improving diagnostic techniques, which continues to drive further growth in the market.

Additionally, the European Union currently has a program called Horizon Europe that allocates very large amounts of money for research in brain tumors, thus impelling cross-border cooperation and innovation. Also, the EU Mission: Cancer further aims to improve the lives of over 3 million cancer patients by 2030. These government initiatives and policies go a long way toward improving brain cancer therapy, ensuring accessibility to treatment worldwide, and improving outcomes for patients. In India, several schemes like Ayushman Bharat help economically vulnerable populations with health insurance coverage ensuring that quality health care is obtained for them. In 2025, the Indian government formally announced its commitment to the establishment of more than 200 daycare cancer centers for patients in diverse states during Budget 2025. These daycare centers will range from many different districts and provide treatment and support to cancer patients.

Global Brain Cancer Therapeutics Market Driver:

Increasing Incidence of Brain Tumors – The growing number of patients suffering from brain tumors is the primary growth driver. According to the American Cancer Society, about 25,400 people are suffering from malignant tumors of the brain or spinal cord, with around 14,420 males and 10,980 females diagnosed. This number takes the lead over non-cancer tumors. By age 40 and above, there were about 79,340 patients diagnosed with primary brain tumors, while around 5,230 people under 20 years of age were diagnosed with central nervous system (CNS) tumors. This creates an intensive requirement for the innovation of therapies such as targeted therapies and immunotherapy, which aim to improve patient outcomes by targeting specific cancer cells and boosting the body's immune response against tumors.

The increasing incidence directly fuels the need for continued development, driving growth in the brain tumor diagnosis and treatment market. This also stresses the immediate necessity of continuous innovation and collaboration among researchers, healthcare providers, and pharmaceutical companies to develop effective therapies and improve patient outcomes, further boosting market demand.

Global Brain Cancer Therapeutics Market Opportunity:

Development of Novel Drug Delivery Systems – The development of new drug delivery systems represents a significant opportunity in the market. Constant problems of getting over blood-brain barriers are faced by traditional medicine delivery methods, creating a requirement for novel drug delivery systems. Recent advances in nanotechnology and targeted delivery systems are gradually alleviating these constraints, bringing on opportunities for market players. Nanoparticles, liposomes, and polymeric micelles are capable of cloaking drugs and directing them precisely to the brain tumor sites without side effects. Convection-enhanced delivery and intranasal delivery effectiveness are emerging as new methods that give a further leap for drug distribution inside the brain. They play a promising role in enhancing therapeutic efficacy and improving the patient's quality of life.

With continuous research, the practical application of the new drug delivery systems will probably bring a very profound change to the treatment of brain cancer and propel market growth. Various companies are capitalizing on this opportunity. For instance, Imvax makes patient-specific vaccines and immunotherapy approaches. Novocure leads Tumor Treating Fields, which is a non-invasive method that uses electric fields to disrupt cancer cells' division.

Global Brain Cancer Therapeutics Market Challenge:

High Cost of Treatment – The exorbitant costs of treatments pose huge obstacles to the Global Brain Cancer Therapies Market. The extreme price of advanced diagnostic tests, surgical procedures, and therapies closes off access for many patients. For instance, craniotomy is the removal of brain tumors and costs between USD 30,000 and USD 100,000. Newer targeted therapies, immunotherapies, and such must be exorbitantly costly because of the intricacies involved and the rigors of research and development.  The high costs of brain cancer treatment strain patients' finances and limit their access to necessary care, making it a global situation even in developed countries.

This situation demands policy interventions besides financial support programs and options to make advanced treatment more affordable, reaching every patient. These high-cost challenges will continue to hamper the market growth during the forecast period if companies along with governments do not initiate some financial assistance programs and efforts to make advanced treatments more affordable and accessible to all patients.

Global Brain Cancer Therapeutics Market Trend:

Advancements in Imaging Technologies – The advancement in imaging technology is shaping the market. Innovation in PET-MRI and advances in MR imaging techniques, including perfusion-weighted imaging, MR spectroscopy, and diffusion-weighted imaging help in better diagnostics of brain tumors with precision. These technologies give diagnostic insights into the characteristics of MRI tumors, thus facilitating appropriate treatment planning and treatment response monitoring.

Further, the combination of radio genomics with machine learning in imaging technology will enhance the specificity and effectiveness of brain cancer treatments. The development of contrast agents and functional imaging will keep advancing the visualization of the metabolism and activity of the tumor. According to these avenues, great advances have been witnessed not only in improving diagnostic accuracy but also in driving personalized medicine, which would ultimately enhance patient outcomes and boost market expansion.

Advanced imaging technologies are revolutionizing the strategy toward brain cancer therapeutics, allowing for therapies to become more dedicated and focused, further offering new hope to cancer patients globally.

Global Brain Cancer Therapeutics Market (2025-30): Segmentation Analysis

The Global Brain Cancer Therapeutics Market study of MarkNtel Advisors evaluates & highlights the major trends and influencing factors in each segment. It includes predictions for the period 2025–2030 at the global level. Based on the analysis, the market has been further classified as:

Based on Therapy:

• Chemotherapy
• Immunotherapy
• Targeted Therapy
• Other

Based on therapy, the immunotherapy segment dominates the market with the largest market share, around 43%. Its advent may be explained by its innovative practice of treating cancer by utilizing the body's immune system. Immunotherapy brings about its action by stimulating or modifying the properly working immune system to get it to better recognize and destroy cancer cells. Treatments like immune checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines are more encouraged due to their improved survival rate and quality of life in brain tumor cases. Additionally, there are fewer side effects compared to traditional treatment options such as chemotherapy which is one of the major reasons for the surging popularity of immunotherapy. Hence immunotherapy is the first and most preferable treatment option for brain cancer.

Based on Type:

• Glioblastoma
• Meningioma
• Pituitary Tumors
• Others

Based on type, Glioblastoma has the largest market share, holding close to 40% in the global market.  This is largely driven by the fact that this is the most common form of brain cancer. For instance, it has an annual diagnosis of nearly 12,000 cases in the United States. Global growth in the market is driven by the increased approvals for glioblastoma therapy drugs. For instance, CNS Pharmaceuticals Inc. obtained IND approval from the US FDA to treat tumors of the brain and central nervous system with Berubicin. Similarly, in 2024, Tovorafenib was authorized by the FDA for the treatment of the most common brain tumors in children. This drug was awarded special approval in patients aged six months or older with either refractory or relapsed pediatric low-grade glioma. Such developments indicate the rising attention given to glioblastoma therapeutics and the growing development of the markets. Therefore, this type of approval supports the treatment of Glioblastoma.

Global Brain Cancer Therapeutics Market (2025-30): Regional Projections

Geographically, the Brain Cancer Therapeutics Market expands across:

• North America
• South America
• Europe
• The Middle East & Africa
• Asia-Pacific

Based on the region, North America has the largest market share, around 60% of the Brain Cancer Therapeutics Industry. It has the largest prevalence of brain tumor cases, coupled with a robust healthcare infrastructure and advanced research capabilities that boost the market demand in the region. For instance, in 2023, as per the American Brain Tumor Association (ABTA), nearly 700,000 people in the United States were living with primary brain and central nervous system tumors. Additionally, around 88,000 new cases are diagnosed annually in the region, which creates a high market demand.

Also, North America has a high number of clinical trials, supported by both the government and private institutions, which drive advancement in brain cancer therapeutics. The combination of increasing brain tumor cases, cutting-edge research, and strong healthcare policies ensure North America remains at the forefront of the Global Brain Cancer Therapeutics Market.

Gain a Competitive Edge with Our Global Brain Cancer Therapeutics Market Report

1. Global Brain Cancer Therapeutics Market Report by MarkNtel Advisors provides a detailed & thorough analysis of market size & share, growth rate, competitive landscape, and key players. This comprehensive analysis helps businesses gain a holistic understanding of the market dynamics & make informed decisions.
2. This report also highlights current market trends & future projections, allowing businesses to identify emerging opportunities & potential challenges. By understanding market forecasts, companies can align their strategies & stay ahead of the competition.
3. The Global Brain Cancer Therapeutics Market Report aids in assessing & mitigating risks associated with entering or operating in the market. By understanding market dynamics, regulatory frameworks, and potential challenges, businesses can develop strategies to minimize risks & optimize their operations.

*Reports Delivery Format - Market research studies from MarkNtel Advisors are offered in PDF, Excel and PowerPoint formats. Within 24 hours of the payment being successfully received, the report will be sent to your email address.